Parveen Goyal

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Molecular Dynamics Simulations

Multidrug Resistant

Acute Myeloid Leukemia

Induced Pluripotent Stem Cells

Top Venues

Journal of medicinal chemistry

Institute for Stem Cell Biology and Regenerative Medicine

Vrije Universiteit Brussel (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute for Stem Cell Biology and Regenerative Medicine Jan 01 2018

India

wellcome dbt india alliance fellow

Goteborgs Universitet May 07 2014 - Sep 30 2017

Sweden

postdoctoral researcher :: department of chemistry and molecular biology

Education History

Vrije Universiteit Brussel Mar 16 2009 - Jan 10 2014

Belgium

PHD :: structural biology

Publications

Gopinath Chattopadhyay, Jayantika Bhowmick, Kavyashree Manjunath, Shahbaz Ahmed, Parveen Goyal, Raghavan Varadarajan
Mechanistic insights into global suppressors of protein folding defects. PLoS genetics 18 (8) (2022)
Stefano Sainas, Agnese C Pippione, Elisa Lupino, Marta Giorgis, Paola Circosta, Valentina Gaidano, Parveen Goyal, Davide Bonanni, Barbara Rolando, Alessandro Cignetti, Alex Ducime, Mikael Andersson, Michael A Järvå, Rosmarie Friemann, Marco Piccinini, Cristina Ramondetti, Barbara Buccinnà, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli
Correction to Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors. Journal of medicinal chemistry 62 (3) (2019)
Stefano Sainas, Agnese C Pippione, Elisa Lupino, Marta Giorgis, Paola Circosta, Valentina Gaidano, Parveen Goyal, Davide Bonanni, Barbara Rolando, Alessandro Cignetti, Alex Ducime, Mikael Andersson, Michael A Järvå, Rosmarie Friemann, Marco Piccinini, Cristina Ramondetti, Barbara Buccinnà, Salam Al-Karadaghi, Donatella Boschi, Giuseppe Saglio, Marco Lucio Lolli
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors. Journal of medicinal chemistry 61 (14) (2018)